Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04344665
Other study ID # v5.0, 2020.09.12
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 23, 2020
Est. completion date June 2, 2021

Study information

Verified date February 2024
Source Population Health Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Post discharge after surgery Virtual Care with Remote Automated Monitoring technology (PVC-RAM) Trial is a multicentre, parallel group, superiority, randomized controlled trial to determine the effect of virtual care with remote automated monitoring (RAM) technology compared to standard care on days alive at home during the 30-day follow-up after randomization, in adults who have undergone semi-urgent (e.g., oncology), urgent (e.g., hip fracture), or emergency (e.g., ruptured abdominal aortic aneurysm) surgery. It will also determine, during the first 30 days, the effect of virtual care with RAM technology on several secondary outcomes, including: 1. hospital re-admission; 2. emergency department visit; 3. urgent-care centre visit; 4. acute-hospital care (i.e., a composite of hospital re-admission and emergency department or urgent-care centre visit) 5. brief acute-hospital care (i.e., acute-hospital care that lasts <24 hours); 6. all-cause hospital days; 7. medication error detection; 8. medication error correction; and 9. death. An additional secondary objective is to determine the effect of virtual care with RAM technology on pain at 7, 15, and 30 days and 6 months after randomization.


Recruitment information / eligibility

Status Completed
Enrollment 905
Est. completion date June 2, 2021
Est. primary completion date October 28, 2020
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: 1. are =40 years of age; 2. have undergone same-day or inpatient semi-urgent, urgent, or emergency surgery and are being discharged home or are within 24 hours after discharge home, as long as they have not had acute-hospital care since their discharge; and 3. provide informed consent to participate. Exclusion Criteria: 1. underwent same-day surgery and the surgeon or anesthesiologist believe the case reflects a traditional same-day surgery case with a low likelihood of needing acute-hospital care; 2. went to rehabilitation or convalescent care for more than 7 days after undergoing surgery; 3. are unable to communicate with research staff, complete study surveys, or undertake an interview using a tablet computer due to a cognitive, language, visual, or hearing impairment; or 4. reside in an area without cellular network coverage and no home Wi-Fi.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual Care and Remote Automated Monitoring
Patients will measure daily vitals (blood pressure, heart rate, respiratory rate, oxygen saturation, temperature, weight) with remote monitoring technology and complete recovery surveys daily in home after discharge from hospital. Patients will interact with a virtual nurse daily on days 1-15 and every other day from days 16-30. If the patient's RAM measurements exceed predetermined thresholds, the patient reports specific symptoms (e.g., shortness of breath), a drug error is identified, or the virtual nurse has concerns about the patient's health that they cannot resolve, the virtual nurse will escalate care to a pre-assigned and available physician. Physicians will add or modify treatments as needed, and if required, they will have the patient come to an outpatient facility for evaluation or management. Via secure video or text messaging, patients will also have access to a virtual nurse at night, for any urgent issues.

Locations

Country Name City State
Canada University of Alberta Hospital Edmonton Alberta
Canada Hamilton General Hospital Hamilton
Canada Juravinski Hospital Hamilton
Canada St. Joseph's Healthcare Hamilton Hamilton
Canada Kingston Health Sciences Centre Kingston
Canada London Health Sciences Centre London
Canada The Ottawa Hospital Ottawa Ontario

Sponsors (3)

Lead Sponsor Collaborator
Population Health Research Institute Hamilton Health Sciences Corporation, McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Health services utilization-related costs Data on hospital re-admission, healthcare utilization, and costs of health service utilization will be obtained from the Institute for Clinical Evaluative Sciences (ICES) data repository 30 Days (after randomization); 6 months (after randomization)
Other Patient level cost of recovery Assessment performed using the Ambulatory Home Care Record 30 Days (after randomization)
Other Re-operation Any surgical procedure undertaken for any reason (e.g., wound dehiscence, infection) 30 Days (after randomization); 6 months (after randomization)
Other Arrythmia resulting in electrical cardioversion Arrythmia resulting in electrical cardioversion 30 Days (after randomization); 6 months (after randomization)
Other Acute renal failure resulting in dialysis Acute renal failure resulting in dialysis 30 Days (after randomization); 6 months (after randomization)
Other Respiratory failure Patient intubated or put on bilevel positive airway pressure (BiPAP). 30 Days (after randomization); 6 months (after randomization)
Other Infection Infection 30 Days (after randomization); 6 months (after randomization)
Other Surgical site infection 30 Days (after randomization); 6 months (after randomization)
Other Life-threatening bleed 30 Days (after randomization); 6 months (after randomization)
Other Major bleed 30 Days (after randomization); 6 months (after randomization)
Other Critical organ bleed 30 Days (after randomization); 6 months (after randomization)
Other Ileus 30 Days (after randomization); 6 months (after randomization)
Other Myocardial Infarction 30 Days (after randomization); 6 months (after randomization)
Other Clinically important atrial fibrillation 30 Days (after randomization); 6 months (after randomization)
Other Symptomatic proximal venous thrombo-embolism 30 Days (after randomization); 6 months (after randomization)
Other Stroke 30 Days (after randomization); 6 months (after randomization)
Other Non-fatal cardiac arrest 30 Days (after randomization); 6 months (after randomization)
Other Clostridium difficile-associated diarrhea 30 Days (after randomization); 6 months (after randomization)
Other Indwelling device 30 Days (after randomization); 6 months (after randomization)
Other COVID-19 Infection 30 Days (after randomization); 6 months (after randomization)
Other Delirium Positive history of delirium in hospital health records, positive 3D-CAM assessment, or FAM-CAM assessment. Assessments performed by telephone or in person. 30 Days (after randomization); 6 months (after randomization)
Other Surgeon, family physician, or specialist in-person clinic visit 30 Days (after randomization); 6 months (after randomization)
Other Sepsis 30 Days (after randomization); 6 months (after randomization)
Other Acute Heart Failure 30 Days (after randomization); 6 months (after randomization)
Other Surgeon, family physician, or specialist virtual visit 30 Days (after randomization); 6 months (after randomization)
Primary Days alive at home Days alive at home are the number of days patients spend at their usual residence - be it a house or apartment, a group home or shelter, a seniors residence, or a nursing home - or at a community residence of a relative, friend, or acquaintance without, during that day, being admitted to a hospital or visiting an emergency department or urgent-care centre. Thus, patients lose days alive at home if 1. patients go to an emergency department or urgent-care centre; 2. they become inpatients at a hospital or rehabilitation or convalescence-care facility; or 3. they die. 30 Days (after randomization); 6 months (after randomization)
Secondary Hospital re-admission 30 Days (after randomization); 6 months (after randomization)
Secondary Emergency Department visit 30 Days (after randomization); 6 months (after randomization)
Secondary Urgent Care centre visit 30 Days (after randomization); 6 months (after randomization)
Secondary Brief acute hospital care 30 Days (after randomization); 6 months (after randomization)
Secondary Medication error detection Medication errors include mistakes in medication prescribing, transcribing, dispensing, administering, or monitoring due to preventable events or actions taken by a patient, caregiver, or healthcare worker. Medication errors include: drug omission (i.e., patient did not take a drug they were supposed to take), drug commission (i.e., patient taking a drug they were not supposed to take), duration error, dosing error, frequency error, route error, and timing error. We will record all drug errors identified and also report whether they resulted in harm. Days 1, 7, 8, 15, 22 and 30 Days (after randomization in the intervention arm), 30 Days (after randomization in the standard care arm and collected on day 31)
Secondary Medication error correction Any medication error that is corrected. Days 1, 7, 8, 15, 22 and 30 Days (after randomization in the intervention arm), 30 Days (after randomization in the standard care arm and collected on day 31)
Secondary Death All cause mortality 30 Days (after randomization); 6 months (after randomization)
Secondary Participant Pain Assessed using the Brief Pain Inventory Short Form (BPI-SF) 7 Days (after randomization); 15 Days (after randomization); 30 Days (after randomization); 6 months (after randomization)
Secondary Acute hospital care Composite of hospital re-admission and emergency department or urgent-care centre visit 30 Days (after randomization); 6 months (after randomization)
Secondary All-cause hospital days If a patient is admitted to the hospital for any reason anytime between midnight and 23:59 on a given day, this will count as a day in hospital. 30 Days (after randomization); 6 months (after randomization)
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Terminated NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A